Generating Killer Cells from Leukemia Patients
Author Information
Author(s): P. Sedlmayr, H. Rabinowich, A. Winkelstein, R.B. Herberman, T.L. Whiteside
Primary Institution: University of Pittsburgh School of Medicine
Hypothesis
The study aims to define conditions for optimal expansion of A-LAK cells in patients with acute myelogenous leukaemia (AML).
Conclusion
The study successfully demonstrates that adding irradiated feeder cells significantly enhances the proliferation and cytotoxicity of A-LAK cells from AML patients.
Supporting Evidence
- Median fold proliferation of A-LAK cells with ConA-activated feeders was 290.
- 7 out of 10 AML patients generated A-LAK cultures with good proliferation.
- A-LAK cells cultured with feeder cells showed up to 90% enrichment in CD3-CD56+ NK cells.
Takeaway
Doctors can grow special immune cells from leukemia patients to help fight their cancer better by using certain techniques.
Methodology
The study involved generating A-LAK cells from cryopreserved peripheral blood mononuclear cells (PBMNC) of AML patients and comparing their proliferation with and without feeder cells.
Limitations
The study does not address the long-term effectiveness of A-LAK cells in actual patient treatment.
Participant Demographics
Patients included both untreated and those in remission from acute myelogenous leukaemia.
Statistical Information
P-Value
p<0.001 for fold expansion with feeder cells
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website